Trial Site Detail


Imatinib, Nilotinib
REGISTER: A multicentre phase 2 study of risk evaluation in GIST with selective therapy escalation for response
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Ongoing, but not recruiting


Ashford Cancer Centre Research

520 South Road     
Kurrulta Park , South Australia 5037


Principal Investigator:
Dusan Kotasek, MD
Sara McLaughlin +08 8351 0211
Activation Status of this Site:
Notes about this Site:
Ashford Cancer Centre Research Website:



Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.